FDA Clears Johnson & Johnson For Wireless Integration Between Blood Glucose Monitor & WellDoc Diabetes Management Platform

The Federal Drug Administration has cleared wireless integration between Johnson & Johnson's OneTouch Verio Flex monitoring system and WellDoc's BlueStar diabetes management platform via Bluetooth capability. BlueStar will use the data to provide a personalized and real-time feedback to consumers and offer virtual coaching for a complete treatment plan. BlueStar will also let physicians make treatment management decisions based on that real-time data. Consumers can access this management solution through a mobile app or a website.

The BlueStar app requires a prescription to download, but is otherwise free to consumers.

Johnson & Johnson has brought innovative . . .